These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 24682874)
1. FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells. Kong Y; Wang H; Wang S; Tang N Inflammation; 2014 Aug; 37(4):1326-36. PubMed ID: 24682874 [TBL] [Abstract][Full Text] [Related]
2. HuR mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis. Chang N; Ge J; Xiu L; Zhao Z; Duan X; Tian L; Xie J; Yang L; Li L J Mol Med (Berl); 2017 Jan; 95(1):69-82. PubMed ID: 27543493 [TBL] [Abstract][Full Text] [Related]
3. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428 [TBL] [Abstract][Full Text] [Related]
4. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. Li C; Kong Y; Wang H; Wang S; Yu H; Liu X; Yang L; Jiang X; Li L; Li L J Hepatol; 2009 Jun; 50(6):1174-83. PubMed ID: 19398237 [TBL] [Abstract][Full Text] [Related]
5. FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration. Hwang SJ; Kim JH; Kim HY; Kim S; Chung DH Lab Invest; 2010 Jan; 90(1):9-19. PubMed ID: 19823172 [TBL] [Abstract][Full Text] [Related]
8. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720. Kihara A; Igarashi Y Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808 [TBL] [Abstract][Full Text] [Related]
9. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis. Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515 [TBL] [Abstract][Full Text] [Related]
10. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. Hisano Y; Kobayashi N; Kawahara A; Yamaguchi A; Nishi T J Biol Chem; 2011 Jan; 286(3):1758-66. PubMed ID: 21084291 [TBL] [Abstract][Full Text] [Related]
11. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells. Butler J; Lana D; Round O; LaMontagne K Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo. Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973 [TBL] [Abstract][Full Text] [Related]
13. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Keller CD; Rivera Gil P; Tölle M; van der Giet M; Chun J; Radeke HH; Schäfer-Korting M; Kleuser B Am J Pathol; 2007 Jan; 170(1):281-92. PubMed ID: 17200201 [TBL] [Abstract][Full Text] [Related]
15. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482 [TBL] [Abstract][Full Text] [Related]
16. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury. Wang L; Sammani S; Moreno-Vinasco L; Letsiou E; Wang T; Camp SM; Bittman R; Garcia JG; Dudek SM Crit Care Med; 2014 Mar; 42(3):e189-99. PubMed ID: 24335440 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. Yang L; Chang N; Liu X; Han Z; Zhu T; Li C; Yang L; Li L Am J Pathol; 2012 Jul; 181(1):85-97. PubMed ID: 22609227 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497 [TBL] [Abstract][Full Text] [Related]
19. [Effects of sphingosine 1-phosphate on functions of T cell - review]. Huang WR; Wang LS; DA WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068 [TBL] [Abstract][Full Text] [Related]
20. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)]. Chiba K Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]